SBIR/STTR Research Award
Far Forward and En Route Decision Assist in the Treatment of Hemorrhage
Award amount
$749,967Program and phase
SBIR · Phase IIAward year
2021Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- DAXOR CORPORATION
- Proposal award date
- 2021-03-11
- Contract end date
- 2022-04-15
- UEI
- QGB8LQAGTAH8
- Solicitation number
- Not reported
- Topic code
- J201-CSO1
Research abstract
Daxor proposes to develop the Fluorescent BVA-200F, a non-nuclear, ruggedized, portable, and forward-deployable version of the commercially available BVA-100. The proposed BVA-200F will be a uniquely accurate, combat-deployable decision assist capability
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Direct Blood Volume Analyzer for Improvement of Combat Casualty Care
- Far Forward and En Route Decision Assist in the Treatment of Hemorrhage
- Precision Guidance of Resuscitation and Deresuscitation in Sepsis
- Development and validation of precision blood volume diagnostic and decision support device for acute decompensated heart failure
- Far Forward and En Route Decision Assist in the Treatment of Hemorrhage
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- AI-enabled Test Incident Report Analysis Tool
- Flight Development of an ASCENT Propellant Decomposition Chamber
- Mage Duel Serious Game - TACFI
- Model Řne: Scalable Multi-Domain Unified C3 Architecture via Secure and Federated Models
- FA557024Q0006 - TACFI - PeakMetrics - JICAF Innovation Information Domain Initiative
Research funding history
8 SBIR/STTR records share this UEI (2019–2024). Reported award amounts total $6,411,058. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Defense, Department of Health and Human Services